// App-Quantinova.ai

e23052 : TOMA OS-Seq: An efficient oligo-selective sequencing solution to identify tumor-specific mutations and copy number alterations.

Researchers

Presenter

  • Yosr Bouhlal

Principal Investigators

  • Yannick Pouliot

  • Jason Stein

  • Janet Ziegle

  • Francisco M. De La Vega

  • Federico Goodsaid

  • Austin P. So

Medical Centers

  • TOMA Biosciences, Foster City, CA

  • TOMA Biosciences, Foster City, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved